Research led by Amsterdam UMC, across more than five years and 1,100 patients has demonstrated a strategy for reducing inappropriate IV use by a third, an effect that was sustained across the five-year period. This should ...
Aug 16, 2024
0
14
A decade ago, federal officials drafted a plan to discourage Medicare Advantage health insurers from overcharging the government by billions of dollars—only to abruptly back off amid an "uproar" from the industry, newly ...
Sep 2, 2024
0
2
A recent study shines light on the treatment and survival outcomes for women with breast cancer in Gaza before the current conflict. While over half of reported diagnoses were made at advanced stages, a high short-term survival ...
Aug 23, 2024
0
0
A new Yale study finds that the effects of long COVID have caused many Americans to miss extensive work time, and that 14% of study participants reported not returning to work in the months after their infection.
Aug 15, 2024
0
60
Major pharmaceutical companies lashed out following a landmark deal unveiled Thursday to cut the costs of 10 key medicines, with some saying the price-setting process was not transparent.
Aug 15, 2024
0
24
Even before the coronavirus pandemic, high rates of burnout and staffing shortages plagued the nursing industry, primarily because of the stressful demands of the job. The COVID-19 pandemic only amplified these challenges, ...
Aug 27, 2024
0
8
Cancer is no longer a death sentence. Across Europe, around 20 million people are now living beyond their disease. But their efforts to return to normal life are severely hampered by a particularly unjust form of financial ...
Aug 15, 2024
0
0
When states require insurers to cover mental and behavioral health, children get better access to care, according to a UC San Francisco-led study of nearly 30,000 U.S. caregivers.
Aug 12, 2024
0
39
On May 13, Sen. Bernie Sanders, I-Vt., published an open letter to Novo Nordisk on the front page of a leading Danish newspaper, urging the hometown company to live up to its altruistic standards by lowering U.S. prices for ...
Aug 13, 2024
0
0
Vaccination against respiratory syncytial virus for adults over 60 is likely to be cost-effective by preventing illness, hospitalizations, lost quality of life and deaths, according to new research.
Sep 5, 2024
0
0
